Intercept Pharma (ICPT) Ticks Higher Ahead of Expected FDA Briefing Docs on OCA in PBC
Intercept Pharma (Nasdaq: ICPT) shares are trading higher Monday as investors are expecting ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
